Drugs (1 - 10 of 323 items)
Rare Diseases: Too Early to Gauge Effectiveness of FDA's Pediatric Voucher Program
GAO-16-319: Published: Mar 2, 2016. Publicly Released: Mar 2, 2016.
Drug Compounding for Animals: FDA Could Improve Oversight with Better Information and Guidance [Reissued on January 8, 2016]
GAO-15-671: Published: Sep 28, 2015. Publicly Released: Sep 28, 2015.
Medicare Part B: Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries
GAO-16-12: Published: Oct 23, 2015. Publicly Released: Nov 20, 2015.
Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
GAO-15-442: Published: Jun 5, 2015. Publicly Released: Jul 6, 2015.
Controlled Substances: DEA Needs to Better Manage Its Quota Process and Improve Coordination with FDA
GAO-15-494T: Published: May 5, 2015. Publicly Released: May 5, 2015.
Drug Discount Program: Status of GAO Recommendations to Improve 340B Drug Pricing Program Oversight
GAO-15-455T: Published: Mar 24, 2015. Publicly Released: Mar 24, 2015.
Drug Shortages: Better Management of the Quota Process for Controlled Substances Needed; Coordination between DEA and FDA Should Be Improved
GAO-15-202: Published: Feb 2, 2015. Publicly Released: Mar 4, 2015.
Drug-Impaired Driving: Additional Support Needed for Public Awareness Initiatives
GAO-15-293: Published: Feb 24, 2015. Publicly Released: Feb 24, 2015.
Prenatal Drug Use and Newborn Health: Federal Efforts Need Better Planning and Coordination
GAO-15-203: Published: Feb 10, 2015. Publicly Released: Feb 10, 2015.
Compounded Drugs: Payment Practices Vary across Public Programs and Private Insurers, and Medicare Part B Policy Should Be Clarified
GAO-15-85: Published: Oct 10, 2014. Publicly Released: Nov 10, 2014.